Literature DB >> 12743012

Early autonomic dysfunction in glucose-tolerant but insulin-resistant offspring of type 2 diabetic patients.

Simona Frontoni1, Daniela Bracaglia, Alessandra Baroni, Fabio Pellegrini, Michela Perna, Elena Cicconetti, Giuseppina Ciampittiello, Guido Menzinger, Sergio Gambardella.   

Abstract

In type 2 diabetes, both insulin resistance and hyperglycemia are considered responsible for autonomic dysfunction, but the specific role of these two abnormalities is not clear. To test the specific role of insulin resistance on autonomic dysfunction, we studied 69 glucose-tolerant offspring of type 2 diabetic patients, comparing the most insulin-resistant tertile (IR) with the most insulin-sensitive tertile (IS) and comparable control subjects, all undergoing the oral glucose tolerance test, impedentiometry, 24-hour blood pressure and ECG monitoring, and an intravenous glucose tolerance test (IVGTT) followed by a euglycemic hyperinsulinemic clamp, with continuous blood pressure and ECG measurements. Sympathovagal balance was evaluated as low- to high-frequency ratio (LF:HF) by spectral analysis on R-R intervals. The change of systolic and diastolic blood pressure was calculated as [(day-night/d)]x100. In IR, the changes of systolic and diastolic blood pressure were significantly lower versus IS (9.2+/-5.0% versus 12.4+/-3.6%, P<0.02; 13.2+/-6.5% versus 17.4+/-5.2%, P<0.02). During the night, LF:HF fall was reduced in IR (43.1+/-21.0 versus 61.4+/-16.9, P<0.02). Hyperinsulinemia (IVGTT) rapidly and significantly increased LF:HF in IR (4.9+/-3.3 versus basal: 2.3+/-1.4, P=0.03) but not in IS. In offspring of type 2 diabetic patients with normal glucose tolerance and normal blood pressure values, insulin resistance is associated with abnormal control of blood pressure and sympathetic activation. Insulin resistance may therefore be responsible for some early derangements of the autonomic nervous tone control and thus contributes to increase the incidence of arterial hypertension and/or diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12743012     DOI: 10.1161/01.HYP.0000073062.29546.01

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

Review 1.  Mediators of sympathetic activation in metabolic syndrome obesity.

Authors:  Nora E Straznicky; Nina Eikelis; Elisabeth A Lambert; Murray D Esler
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

2.  Food-intake dysregulation in type 2 diabetic Goto-Kakizaki rats: hypothesized role of dysfunctional brainstem thyrotropin-releasing hormone and impaired vagal output.

Authors:  K Zhao; Y Ao; R M Harper; V L W Go; H Yang
Journal:  Neuroscience       Date:  2013-05-20       Impact factor: 3.590

3.  Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.

Authors:  Nora E Straznicky; Mariee T Grima; Carolina I Sari; Nina Eikelis; Elisabeth A Lambert; Paul J Nestel; Murray D Esler; John B Dixon; Reena Chopra; Alan J Tilbrook; Markus P Schlaich; Gavin W Lambert
Journal:  Diabetes       Date:  2012-06-04       Impact factor: 9.461

4.  Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients.

Authors:  Alessandra Di Flaviani; Fabiana Picconi; Paola Di Stefano; Ilaria Giordani; Ilaria Malandrucco; Paola Maggio; Paola Palazzo; Fabrizio Sgreccia; Carlo Peraldo; Fabrizio Farina; Gaetano Frajese; Simona Frontoni
Journal:  Diabetes Care       Date:  2011-05-24       Impact factor: 19.112

5.  Circadian rhythm of autonomic activity in non diabetic offsprings of type 2 diabetic patients.

Authors:  A Fiorentini; A Perciaccante; A Paris; P Serra; L Tubani
Journal:  Cardiovasc Diabetol       Date:  2005-10-01       Impact factor: 9.951

6.  Relationship of resting heart rate and physical activity with insulin sensitivity in a population-based survey.

Authors:  Andrew Grandinetti; David Mki Liu; Joseph Keawe'aimoku Kaholokula
Journal:  J Diabetes Metab Disord       Date:  2015-05-06

7.  Norepinephrine transporter expression is inversely associated with glycaemic indices: a pilot study in metabolically diverse persons with overweight and obesity.

Authors:  N E Straznicky; L Guo; S J Corcoran; M D Esler; S E Phillips; C I Sari; M T Grima; S Karapanagiotidis; C Y Wong; N Eikelis; J A Mariani; D Kobayashi; J B Dixon; G W Lambert; E A Lambert
Journal:  Obes Sci Pract       Date:  2016-01-19

Review 8.  Exercise therapy in type 2 diabetes.

Authors:  Stephan F E Praet; Luc J C van Loon
Journal:  Acta Diabetol       Date:  2009-05-29       Impact factor: 4.280

9.  Parental history of type 2 diabetes, TCF7L2 variant and lower insulin secretion are associated with incident hypertension. Data from the DESIR and RISC cohorts.

Authors:  Fabrice Bonnet; Ronan Roussel; Andrea Natali; Stéphane Cauchi; John Petrie; Martine Laville; Loïc Yengo; Philippe Froguel; Céline Lange; Olivier Lantieri; Michel Marre; Beverley Balkau; Ele Ferrannini
Journal:  Diabetologia       Date:  2013-08-14       Impact factor: 10.122

Review 10.  Autonomic Nervous System in Obesity and Insulin-Resistance-The Complex Interplay between Leptin and Central Nervous System.

Authors:  Benedetta Russo; Marika Menduni; Patrizia Borboni; Fabiana Picconi; Simona Frontoni
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.